Vitamin Shoppe Inc. (NYSE:VSI) gapped up before the market opened on Friday . The stock had previously closed at $30.69, but opened at $30.97. Vitamin Shoppe shares last traded at $31.64, with a volume of 69,414 shares traded.

Several research firms recently weighed in on VSI. Robert W. Baird reiterated a “hold” rating on shares of Vitamin Shoppe in a research note on Tuesday, April 26th. William Blair cut shares of Vitamin Shoppe to a “market perform” rating in a research report on Monday, March 28th. Piper Jaffray Cos. restated a “neutral” rating and issued a $30.00 target price on shares of Vitamin Shoppe in a research report on Friday, April 15th. Zacks Investment Research cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Wednesday, April 20th. Finally, Wedbush began coverage on shares of Vitamin Shoppe in a research report on Wednesday, April 20th. They issued an “outperform” rating and a $39.00 target price for the company. One research analyst has rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $32.82.

The firm has a 50 day moving average price of $30.37 and a 200 day moving average price of $30.04. The firm has a market capitalization of $757.59 million and a PE ratio of 18.12.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.67 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.02. The business had revenue of $336.80 million for the quarter, compared to the consensus estimate of $339.76 million. During the same period in the previous year, the business posted $0.63 earnings per share. Vitamin Shoppe’s revenue was up .0% on a year-over-year basis. On average, equities analysts predict that Vitamin Shoppe Inc. will post $2.32 EPS for the current fiscal year.

In other Vitamin Shoppe news, Director Guillermo Marmol acquired 1,000 shares of Vitamin Shoppe stock in a transaction dated Tuesday, May 31st. The stock was bought at an average cost of $30.23 per share, with a total value of $30,230.00. Following the acquisition, the director now owns 1,470 shares of the company’s stock, valued at $44,438.10. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Other institutional investors have added to or reduced their stakes in the company. California State Teachers Retirement System increased its position in Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock worth $1,802,000 after buying an additional 885 shares during the last quarter. Rhumbline Advisers increased its position in shares of Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock valued at $1,475,000 after buying an additional 1,855 shares in the last quarter. Gabelli Funds LLC increased its position in shares of Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock valued at $1,734,000 after buying an additional 7,000 shares in the last quarter. State of Wisconsin Investment Board increased its position in shares of Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock valued at $5,203,000 after buying an additional 1,229 shares in the last quarter. Finally, Olstein Capital Management L.P. increased its position in shares of Vitamin Shoppe by 22.9% in the fourth quarter. Olstein Capital Management L.P. now owns 472,000 shares of the company’s stock valued at $15,434,000 after buying an additional 88,000 shares in the last quarter.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.